Hironic Co., Ltd. (149980) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Hironic Co., Ltd. (149980:KRX), powered by AI.

Current Price
₩7,300
P/E Ratio
-22.3
Market Cap
154.7B
Sector
Healthcare
What is the Hironic Co., Ltd. stock price forecast?

Hironic Co., Ltd. is currently trading at ₩7,300. View real-time AI analysis on Alpha Lenz.

What is Hironic Co., Ltd. insider trading activity?

View the latest insider trading data for Hironic Co., Ltd. on Alpha Lenz.

What is Hironic Co., Ltd.'s P/E ratio?

Hironic Co., Ltd.'s P/E ratio is -22.3.

Hironic Co., Ltd.

KRX · 149980
₩7,300
Ask about Hironic Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Hironic Co., Ltd. trades at a P/E of -22.3 (undervalued) with modest ROE of -7.7%. 3Y revenue CAGR of 13.2% highlights clear growth momentum.

Ask for details

Company Overview

Hironic Co., Ltd. is a prominent player in the medical device industry, primarily focusing on the development and manufacture of innovative aesthetic and medical treatment equipment. The company specializes in technologies related to skin rejuvenation, body contouring, and laser-based devices, catering to both professional clinics and consumer markets. Its product lineup includes high-intensity focused ultrasound (HIFU) systems and radiofrequency devices, which are widely used in non-invasive cosmetic procedures to enhance skin appearance and reduce wrinkles without the need for surgery. As a significant contributor to the aesthetic medical device market, Hironic Co., Ltd. is at the forefront of integrating advanced technology and clinical research to improve the safety and efficacy of its products. The company's innovative solutions have made substantial impacts in dermatology and cosmetic medicine, playing a vital role in expanding accessible self-care options for beauty and healthcare professionals globally. Based in South Korea, Hironic Co., Ltd. taps into both the domestic and international markets, reflecting the increasing global demand for minimally invasive cosmetic interventions.

CEO이진우
SectorHealthcare
IndustryMedical Devices
Employees117

Company Statistics

FY 2024

Profile

₩154,718,849,900Market Cap
₩31,628,770,810Revenue
21.19MShares Out
117Employees

Margins

43.72%Gross
-8.41%EBITDA
-15.04%Operating
-21.49%Pre-Tax
-17.34%Net

Valuation

-22.35P/E
1.75P/B
3.85EV/Sales
-44.77EV/EBITDA
36.18P/FCF

Growth (CAGR)

13.24%Rev 3Yr
15.40%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-6.90%ROA
-7.68%ROE
-8.49%ROIC

Financial Health

₩2,833,459,070Cash & Cash Equivalents
₩7,342,635,720Net Debt
14.57%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Hironic Co., Ltd. (ticker: 149980) is a company listed on KRX in the Healthcare sector (Medical Devices). It has approximately 117 employees. Market cap is $154.7B.

The current price is ₩7,300 with a P/E ratio of -22.35x and P/B of 1.75x.

ROE is -7.68% and operating margin is -15.04%. Annual revenue is $31.6B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Hironic Co., Ltd. (Healthcare) Stock Forecast & Analysis ₩7,300 | Alpha Lenz